Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The muscarinic acetylcholine receptor M1 (M1 mAChR or CHRM1) is a G protein-coupled receptor that mediates cellular responses to acetylcholine. It is highly expressed in the central nervous system and plays a critical role in cognitive processes, glandular secretion, and synaptic modulation. It is a target for drug development for neurological disorders. Antagonism of M1 can cause delirium.
Agonists bind to the M1 receptor, activating Gq/11 proteins, leading to increased phospholipase C activity, IP3 production, and intracellular calcium levels. Antagonists block acetylcholine binding, inhibiting downstream signaling.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Muscarinic Acetylcholine Receptor M1 (M1 mAChR).